SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
SEC Accession No. 0000921895-17-001629
Filing Date
2017-05-24
Accepted
2017-05-24 16:36:59
Documents
1

Document Format Files

Seq Description Document Type Size
1 THE SCHEDULE 13G sc13g07216enz_05232017.htm SC 13G 57321
  Complete submission text file 0000921895-17-001629.txt   58873
Mailing Address 20 COMMERCE DRIVE, SUITE 135 CRANFORD NJ 07016
Business Address 20 COMMERCE DRIVE, SUITE 135 CRANFORD NJ 07016 732-980-4500
ENZON PHARMACEUTICALS, INC. (Subject) CIK: 0000727510 (see all company filings)

IRS No.: 222372868 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-35587 | Film No.: 17867110
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 800 THIRD AVENUE 31ST FLOOR NEW YORK NY 10022
Business Address
COUCHMAN JONATHAN (Filed by) CIK: 0001265094 (see all company filings)

Type: SC 13G